Fractionated photoimmunotherapy stimulates an anti-tumour immune response: an integrated mathematical and in vitro study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Fractionated photoimmunotherapy stimulates an anti-tumour immune response: an integrated mathematical and in vitro study ; volume:131 ; number:8 ; day:11 ; month:9 ; year:2024 ; pages:1378-1386 ; date:11.2024
British journal of cancer ; 131, Heft 8 (11.9.2024), 1378-1386, 11.2024
- Urheber
-
Zahid, Mohammad U.
Waguespack, Matthew
Harman, Rebecca C.
Kercher, Eric M.
Nath, Shubhankar
Hasan, Tayyaba
Rizvi, Imran
Spring, Bryan Q.
Enderling, Heiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-024-02844-y
- URN
-
urn:nbn:de:101:1-2501012122134.552636042339
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
05.11.20252025, 20:00 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zahid, Mohammad U.
- Waguespack, Matthew
- Harman, Rebecca C.
- Kercher, Eric M.
- Nath, Shubhankar
- Hasan, Tayyaba
- Rizvi, Imran
- Spring, Bryan Q.
- Enderling, Heiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Acid affairs in anti-tumour immunity
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Tumour oxygenation during fractionated radiotherapy: comparison with size-matched controls
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
The Evolution of Tumour Composition During Fractionated Radiotherapy: Implications for Outcome
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Acid affairs in anti-tumour immunity
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Tumour oxygenation during fractionated radiotherapy: comparison with size-matched controls
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
The Evolution of Tumour Composition During Fractionated Radiotherapy: Implications for Outcome
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Acid affairs in anti-tumour immunity
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Tumour oxygenation during fractionated radiotherapy: comparison with size-matched controls
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy